Various Challenges Associated with the Metabolomics is expected to hinder the Global Metabolomics Market over the Forecast Period
The systematic identification and
measurement of all metabolites in a given organism or biological sample is
known as metabolomics. Studies on the small molecule biochemistry of bacteria,
plants, and mammals have increased as a result of the development of nuclear
magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and powerful
chemometric software that allows the simultaneous determination and comparison
of thousands of chemical entities. The two main categories of metabolomics
services are targeted and untargeted.
Due to increased government and
private funding for research and development, as well as the rise in metabolic
applications in personalised medicine, the global
metabolomics market is anticipated to experience a profitable growth
rate during the forecast period. In terms of size, the market is dominated by
instruments, largely because metabolomics equipment is used extensively while
carrying out the various steps of the experimental protocol. Metabolomics
bioinformatics tools and services are anticipated to grow more quickly in the
future because they make it easier to analyse and interpret biological data
that is already widely available.
Numerous fields, such as
biomarker discovery, drug discovery, toxicology testing, nutrigenomics,
functional genomics, personalised medicine, and others, have found extensive
use for metabolomics. Due to the rise in the prevalence of chronic diseases on
a global scale, the biomarker discovery field accounted for the majority of
metabolomics' application areas in 2016. Additionally, the Metabolomics market greater
contribution to biomarker discovery is driven by extensive oncological research
with a bias toward the study of new biomarkers and their cancer applications.
Comments
Post a Comment